We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+8.41%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$110B
AUM Growth
+$8.55B
(+8.4%)
Cap. Flow
+$733M
Cap. Flow
% of AUM
0.67%
Top 10 Holdings %
Top 10 Hldgs %
32.31%
Holding
285
New
9
Increased
94
Reduced
125
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$381M |
| 2 |
AstraZeneca
AZN
|
+$242M |
| 3 |
Citigroup
C
|
+$201M |
| 4 |
Bath & Body Works
BBWI
|
+$145M |
| 5 |
Hewlett Packard
HPE
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$267M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$160M |
| 3 |
Amgen
AMGN
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$146M |
| 5 |
Medtronic
MDT
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 23.76% |
| 3 | Industrials | 15.73% |
| 4 | Consumer Discretionary | 8.92% |
| 5 | Financials | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Oracle
ORCL
$346B
| $315M | 0.29% |
7,070,450
-27,850
| -0.4% | -$1.16M |
|
77
Merck
MRK
$322B
| $310M | 0.28% |
5,109,314
+2,008,177
| +65% | +$122M |
|
78
Aecom
ACM
$8.69B
| $307M | 0.28% |
8,636,075
+1,212,050
| +16% | +$44.3M |
|
79
SLB Ltd
SLB
$70.6B
| $304M | 0.28% |
3,891,478
+19,246
| +0.5% | +$1.57M |
|
|
YHOO
80
DELISTED
Yahoo Inc
YHOO
| $290M | 0.26% |
6,249,330
-47,700
| -0.8% | -$2.13M |
|
81
Amazon
AMZN
$2.51T
| $282M | 0.26% |
6,351,760
+159,000
| +3% | +$6.63M |
|
|
POLY
82
DELISTED
Plantronics, Inc.
POLY
| $266M | 0.24% |
4,923,150
| – | – |
|
83
CVS Health
CVS
$136B
| $266M | 0.24% |
3,391,470
-17,630
| -0.5% | -$1.41M |
|
84
US Bancorp
USB
$98.7B
| $261M | 0.24% |
5,059,550
-32,850
| -0.6% | -$1.75M |
|
|
SFLY
85
DELISTED
Shutterfly, Inc.
SFLY
| $257M | 0.23% |
5,329,482
-200
| -0% | -$9.61K |
|
86
Norwegian Cruise Line
NCLH
$8.59B
| $253M | 0.23% |
4,986,475
-42,900
| -0.9% | -$2.08M |
|
87
Dell
DELL
$284B
| $252M | 0.23% |
14,015,042
-129,224
| -0.9% | -$2.25M |
|
88
Agilent Technologies
A
$39.5B
| $252M | 0.23% |
4,765,730
+110,900
| +2% | +$5.6M |
|
89
ASML
ASML
$693B
| $245M | 0.22% |
1,842,015
-22,998
| -1% | -$2.83M |
|
|
NSR
90
DELISTED
Neustar Inc
NSR
| $243M | 0.22% |
7,319,152
+16,406
| +0.2% | +$545K |
|
91
Applied Materials
AMAT
$447B
| $239M | 0.22% |
6,155,507
+236,952
| +4% | +$8.51M |
|
92
Wolfspeed
WOLF
$1.35B
| $234M | 0.21% |
8,768,141
-85,100
| -1% | -$2.31M |
|
93
CME Group
CME
$91.9B
| $231M | 0.21% |
1,941,913
+800
| +0% | +$96.2K |
|
94
Insulet
PODD
$11B
| $223M | 0.2% |
5,178,572
-700
| -0% | -$30K |
|
95
Northern Trust
NTRS
$21.9B
| $221M | 0.2% |
2,553,950
+592,550
| +30% | +$51.5M |
|
96
EOG Resources
EOG
$77.5B
| $214M | 0.19% |
2,194,150
-425
| -0% | -$42.4K |
|
97
PayPal
PYPL
$49.4B
| $213M | 0.19% |
4,957,900
+144,200
| +3% | +$6.03M |
|
98
CSX Corp
CSX
$98.1B
| $213M | 0.19% |
13,711,125
-1,161,675
| -8% | -$17.7M |
|
|
NUAN
99
DELISTED
Nuance Communications, Inc.
NUAN
| $206M | 0.19% |
13,746,308
+82,255
| +0.6% | +$1.17M |
|
100
Revvity
RVTY
$12.6B
| $205M | 0.19% |
3,531,955
+25,825
| +0.7% | +$1.41M |
|
Similar funds
Primecap Management's Q1 2017 Portfolio in Review
As of Q1 2017, Primecap Management held 285 positions worth $110B, up 8.4% from $102B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2017: portfolio turnover was 4.2%. Primecap Management opened 9 new positions and exited 3, leaving the 285-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 7,741,094 shares worth $422M.
- Primecap Management added most to AstraZeneca in Q1 2017, an estimated $242M increase.
- Primecap Management's biggest Q1 2017 reduction was Intel, cutting an estimated $267M.
- Primecap Management fully exited C.H. Robinson in Q1 2017, selling an estimated $14.4M.
- Primecap Management's ten largest holdings make up 32% of its $110B portfolio in Q1 2017.
- Primecap Management opened 9 new positions and closed 3 in Q1 2017.
- Primecap Management's portfolio value rose 8.4% quarter-over-quarter to $110B.
Based on Primecap Management's 13F filing for Q1 2017, filed 12 May 2017.